These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35144315)

  • 1. The HUNT study: Association of comorbidity clusters with long-term survival and incidence of exacerbation in a population-based Norwegian COPD cohort.
    Vikjord SAA; Brumpton BM; Mai XM; Romundstad S; Langhammer A; Vanfleteren L
    Respirology; 2022 Apr; 27(4):277-285. PubMed ID: 35144315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.
    Suissa S; Dell'Aniello S; Ernst P
    Thorax; 2012 Nov; 67(11):957-63. PubMed ID: 22684094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
    Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
    Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.
    Whittaker H; Rubino A; Müllerová H; Morris T; Varghese P; Xu Y; De Nigris E; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2022; 17():427-437. PubMed ID: 35264849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study.
    Kim Y; Kim YJ; Kang YM; Cho WK
    BMC Pulm Med; 2021 May; 21(1):151. PubMed ID: 33957924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Goto T; Hirayama A; Faridi MK; Camargo CA; Hasegawa K
    Ann Am Thorac Soc; 2018 Feb; 15(2):184-191. PubMed ID: 29053337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study.
    Kang EH; Jin Y; Desai RJ; Liu J; Sparks JA; Kim SC
    Semin Arthritis Rheum; 2020 Jun; 50(3):401-408. PubMed ID: 31813561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends in the Incidence of Heart Failure among Patients with Chronic Obstructive Pulmonary Disease and Its Association with Mortality.
    Axson EL; Sundaram V; Bloom CI; Bottle A; Cowie MR; Quint JK
    Ann Am Thorac Soc; 2020 Aug; 17(8):939-948. PubMed ID: 32275836
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations.
    Spece LJ; Epler EM; Donovan LM; Griffith MF; Collins MP; Feemster LC; Au DH
    Ann Am Thorac Soc; 2018 Sep; 15(9):1033-1038. PubMed ID: 30079748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association of Bone Mineral Density with Mortality in a COPD Cohort. The HUNT Study, Norway.
    Vikjord SAA; Brumpton BM; Mai XM; Bhatta L; Vanfleteren L; Langhammer A
    COPD; 2019 Dec; 16(5-6):321-329. PubMed ID: 31709837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.
    Schmidt SA; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Sørensen HT; Christiansen CF
    BMJ Open; 2014 Dec; 4(12):e006720. PubMed ID: 25526796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostication of co-morbidity clusters on hospitalisation and mortality in advanced COPD.
    James BD; Greening NJ; Tracey N; Haldar P; Woltmann G; Free RC; Steiner MC; Evans RA; Ward TJ
    Respir Med; 2024 Feb; 222():107525. PubMed ID: 38182000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.